Grant Michael Dixton, Executive Vice President at General Motors Co. (), sold 40,000 shares of the company’s common stock on August 3, 2026. The shares were sold at a weighted average price of $88.44, with individual transactions ranging from $87.31
Michael L. Goldstone, Senior Vice President, General Counsel, and Corporate Secretary at Rush Enterprises Inc. (), recently sold 4,500 shares of the company’s Class A Common Stock for a total value of approximately $365,242. These sales followed
Scott Mezvinsky, CEO of KFC Division at YUM Brands Inc. (), sold common stock valued at $41,044 on August 3, 2026. The shares were sold at a price of $153.15 each. The transaction involved the sale of 268 shares of YUM
ADAR1 Capital Management, LLC, a 10% owner and director of NextCure, Inc. (), acquired common stock totaling $1,624,120 through multiple transactions on July 30 and July 31, 2026. The investment firm purchased a total of 329,153 shares of NextCure common stock. The
Brian Daniel Webster, President and Chief Executive Officer at KESTRA MEDICAL TECHNOLOGIES, LTD. (), sold common shares worth approximately $692,214 in a series of transactions between July 30 and August 3, 2026. The shares were sold at prices ranging from $22.6039
Christian Kleinerman, Executive Vice President of Product Management at Snowflake Inc. (), sold 29,986 shares of common stock on July 31, 2026. The transactions, executed at a price of $300 per share, totaled $8,995,800. These sales were conducted under a pre-arranged 10
Timothy P. Moran, Chief Business Officer at Kestra Medical Technologies, Ltd. (), sold a total of 15,256 common shares of the company’s stock across three transactions from July 30 to August 3, 2026. The sales amounted to a total
Maryann Bruce, a Director at Amalgamated Financial Corp. (), disposed of 2,138 shares of common stock on July 30, 2026. The transactions totaled $105,942. The shares were sold at a weighted average price of $49.5522 per share. According to a footnote
Amit Kumar, Chief Executive Officer and a Director at Anixa Biosciences Inc (), acquired 5,000 shares of the company’s common stock on July 31, 2026. The transaction totaled $17,350, with shares purchased at a price of $3.47 each. The purchase
Laura C. Kendall, a director at HomeTrust Bancshares, Inc. (), recently sold 10,000 shares of common stock for a total value of $511,348. The transactions, which occurred on July 30, 2026, also included the acquisition of 10,000 shares through the exercise
